Status:
UNKNOWN
The Effect of Beta-blockers in Substance P Levels and the Swallowing Function
Lead Sponsor:
Hospital de Mataró
Conditions:
Beta Blockers
Swallowing Disorder
Eligibility:
All Genders
Brief Summary
A non-randomised, prospective study to assess the effects of beta-blockers on substance P levels and the swallowing function. The study is going to be carry out in the Gastrointestinal Physiology Labo...
Eligibility Criteria
Inclusion
- \- Patients taking and not taking beta-blockers
Exclusion
- Participants with heat and neck or esophageal cancer
- Participants with stroke or neurological disease
- Participants with central nervous system disease
- Participants with concomitant treatment with Angiotensin converting enzyme inhibitors (ACEI), Angiotensin II receptor antagonists (ARA-II), Antipsychotics, Dopamine agonists, Capsaicine.
- Participants with severe clinical signs of aspiration, including oxygen desaturation ≥3%.
Key Trial Info
Start Date :
June 5 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03306134
Start Date
June 5 2017
End Date
December 31 2018
Last Update
February 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mataró Hospital
Mataró, Barcelona, Spain, 08304